Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Exp Hematol ; 20(9): 1118-24, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1281786

ABSTRACT

The cDNA for canine stem cell factor (cSCF, c-kit ligand) was cloned and expressed in Escherichia coli. The recombinant protein (rcSCF), 165 amino acids in length, is very similar structurally to the soluble form of previously cloned and sequenced rodent and human SCFs. The biological effects of rcSCF were studied in a day-10 granulocyte-macrophage colony-forming unit (CFU-GM) clonogenic assay and in long-term liquid bone marrow culture of non-adherent hematopoietic cells in the absence of a stromal underlayer. Synergism in the stimulation of growth of CFU-GM was demonstrated between rcSCF and both recombinant human (rh) granulocyte-macrophage colony-stimulating factor (GM-CSF) and naturally occurring colony-stimulating activity present in the serum of a neutropenic dog. Alone, rcSCF was nonstimulatory for committed marrow precursors in methylcellulose cultures and had minimal effect on hematopoietic progenitor cell survival in stromaless, liquid cultures. When rcSCF was combined with phytohemagglutinin-stimulated canine lymphocyte-conditioned medium (PHA-LCM) or rh interleukin 6 (IL-6), with or without rhGM-CSF, CFU-GM survived for up to 5 weeks. The combination of rcSCF and rhGM-CSF, without rhIL-6, led to an early increase in CFU-GM in liquid cultures that declined more rapidly than in flasks that included rhIL-6. Survival of progenitor cells was negligible beyond 1 week in flasks with growth factor combinations lacking rcSCF. Sustained production of nonadherent cells in long-term cultures also was dependent on rcSCF in combination with canine PHA-LCM or recombinant human growth factors. It appears that rcSCF, like that from rodent and primate species, has the ability to influence the survival and proliferation of CFU-GM, and perhaps earlier progenitor cells, in hematopoietic tissues. In a long-term liquid culture system in which growth factor production by stromal cells is limited, rcSCF possesses a unique ability to maintain the viability of progenitor cells for up to 5 weeks.


Subject(s)
Bone Marrow Cells , Hematopoietic Cell Growth Factors/pharmacology , Hematopoietic Stem Cells/physiology , Amino Acid Sequence , Animals , Base Sequence , Bone Marrow/drug effects , Bone Marrow/physiology , Cell Division/drug effects , Cell Division/physiology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Dogs , Drug Synergism , Hematopoietic Cell Growth Factors/genetics , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/drug effects , Interleukin-6/pharmacology , Molecular Sequence Data , Phytohemagglutinins/pharmacology , Recombinant Proteins/pharmacology , Stem Cell Factor
2.
Cell ; 63(1): 203-11, 1990 Oct 05.
Article in English | MEDLINE | ID: mdl-2208279

ABSTRACT

Partial cDNA and genomic clones of rat stem cell factor (SCF) have been isolated. Using probes based on the rat sequence, partial and full-length cDNA and genomic clones of human SCF have been isolated. Based on the primary structure of the 164 amino acid protein purified from BRL-3A cells, truncated forms of the rat and human proteins have been expressed in E. coli and mammalian cells and have been shown to possess biological activity. SCF is able to augment the proliferation of both myeloid and lymphoid hematopoietic progenitors in bone marrow cultures. SCF exhibits potent synergistic activities in conjunction with colony-stimulating factors, resulting in increased colony numbers and colony size.


Subject(s)
DNA/genetics , Hematopoietic Cell Growth Factors/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Division/drug effects , Cloning, Molecular , DNA/isolation & purification , Gene Expression , Genes , Genomic Library , Growth Substances/pharmacology , Hematopoietic Cell Growth Factors/isolation & purification , Hematopoietic Cell Growth Factors/pharmacology , Humans , Molecular Sequence Data , Oligonucleotide Probes , Plasmids , Protein Conformation , Rats , Recombinant Proteins/isolation & purification , Recombinant Proteins/pharmacology , Sequence Homology, Nucleic Acid
3.
Cell ; 63(1): 213-24, 1990 Oct 05.
Article in English | MEDLINE | ID: mdl-1698556

ABSTRACT

We have cloned a partial cDNA encoding murine stem cell factor (SCF) and show that the gene is syntenic with the Sl locus on mouse chromosome 10. Using retroviral vectors to immortalize fetal liver stromal cell lines from mice harboring lethal mutations at the Sl locus (Sl/Sl), we have shown that SCF genomic sequences are deleted in these lines. Furthermore, two other mutations at Sl, Sld and Sl12H, are associated with deletions or alterations of SCF genomic sequences. In vivo administration of SCF can reverse the macrocytic anemia and locally repair the mast cell deficiency of Sl/Sld mice. We have also provided biological and physical evidence that SCF is a ligand for the c-kit receptor.


Subject(s)
Chromosome Mapping , Hematopoietic Cell Growth Factors/genetics , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Amino Acid Sequence , Anemia, Macrocytic/drug therapy , Anemia, Macrocytic/genetics , Animals , Base Sequence , Cell Line , Cloning, Molecular , Cricetinae , DNA/genetics , DNA/isolation & purification , Genes , Hematopoietic Cell Growth Factors/metabolism , Hematopoietic Cell Growth Factors/therapeutic use , Hybrid Cells/cytology , Ligands , Mice , Mice, Mutant Strains , Molecular Sequence Data , Mutation , Proto-Oncogene Proteins c-kit , Rats , Recombinant Proteins/therapeutic use , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL